Table 6

RWT Change During 12 Months and Risk of Subsequent VAs

Outcome (Number of Events)HR95% CIp Value
VT/VF (n = 153)0.660.45–0.950.027
VT ≥200/VF (n = 95)0.680.41–1.140.141
VT/VF/death (n = 194)0.640.46–0.890.009
VT (n = 133)0.680.46–1.000.052
VF (n = 39)0.510.23–1.160.108

Abbreviations as in Tables 1 and 2.

  • HR per 10% increase in RWT at 12 months compared with baseline. Adjusted for CRT-D therapy, female sex, glomerular filtration rate, previous myocardial infarction, New York Heart Association functional class, QRS duration ≥150 ms, SBP, previous VA, and age at enrollment.